# Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons

> **NCT00463086** · NA · COMPLETED · sponsor: **University of Cape Town** · enrollment: 1368 (actual)

## Conditions studied

- Tuberculosis
- Latent Tuberculosis Infection
- HIV Infections

## Interventions

- **DRUG:** isoniazid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00463086
- **Lead sponsor:** University of Cape Town
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 1368 (ACTUAL)
- **Last updated:** 2012-07-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463086, "Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00463086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*